Abbott Laboratories 9MCY26 profit rises 25% to nearly Rs7bn
Mettis Global • • 1 min read
%2520LIMITED%2520(1).png%3Fwidth%3D950%26height%3D450%26format%3DWebp&w=3840&q=75)
Abbott Laboratories (Pakistan) Limited (ABOT) reported net profit of Rs6.68 billion for the nine months ended September 30, 2026, an increase of 24.57% from Rs5.37 billion a year earlier, Mettis Global reported. Earnings per share rose 24.58% to Rs68.28, while net sales advanced 4.32% to Rs58.66 billion.
Local sales grew 5.99% to Rs57.14 billion, but exports dropped 34.40% to Rs1.52 billion. Cost of sales eased 1.20%, lifting gross profit 14.86% to Rs22.21 billion; operating expenses increased 6.25% to Rs10.76 billion. Operating profit rose 24.32% to Rs11.45 billion, while lower finance costs and higher other income also featured in the period’s results.
At a glance
- ABOT’s nine-month net profit increased 24.57% to Rs6.68 billion.
- Net sales rose 4.32% to Rs58.66 billion, while exports fell 34.40%.
- Earnings per share increased 24.58% to Rs68.28.
Stocks in this story
Originally reported by Mettis Global
This page is Investify's own summary. The full report, with all details and context, is on the publisher's site.
Read the full storyWant the full article here?
Log in to read the full article in the Investify reader, in English or Urdu.
Investify summarizes Pakistan Stock Exchange news in its own words and links each story to its original publisher. We always credit the source so you can read the full report and verify the details before making financial decisions.
More on ABOT
PSX Closing Bell: Green Day, Great DayMettis• 27 Oct 2026
Nishat Power 1QFY27 profit falls 7% to around Rs541mMettis• 27 Oct 2026
Gold price in Pakistan falls Rs1,300 per tolaMettis• 27 Oct 2026
Palm falls nearly 2% on weaker Dalian oils, high stockpilesBR• 27 Oct 2026
Indian rupee boxed in range; traders focus on oil, outflows and RBI's defenceBR• 27 Oct 2026
Oil rises as hopes for diplomacy offset impact of renewed Houthi attacksBR• 27 Oct 2026
